Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression-Reference-Cited by-同舟云学术

Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression

Published:2018-12-18 Issue:2 Volume:129 Page:569-582
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Song Bing,Park Su-Hong,Zhao Jonathan C.,Fong Ka-wing,Li Shangze,Lee Yongik,Yang Yeqing A.,Sridhar Subhasree,Lu Xiaodong,Abdulkadir Sarki A.,Vessella Robert L.,Morrissey Colm,Kuzel Timothy M.^ORCID,Catalona William,Yang Ximing,Yu Jindan

Funder

NIH Office of the Director

Prostate Cancer Foundation of Australia

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/122367/files/pdf

Reference45 articles.

1. Cancer statistics, 2018

2. Abiraterone and Increased Survival in Metastatic Prostate Cancer

3. Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

4. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer

5. Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment-induced stemness and lineage plasticity in driving prostate cancer therapy resistance;Cancer Heterogeneity and Plasticity;2024-08-25

2. The Role of FOXA1 in Human Normal Development and Its Functions in Sex Hormone-Related Cancers;Frontiers in Bioscience-Landmark;2024-06-21

3. Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial;Clinical Cancer Research;2024-05-24

4. FOXA1 is required for ErbB2 expression and luminal differentiation in HER2-positive breast cancer;2024-04-20

5. FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer;Cell Death Discovery;2024-04-11